MoonLake Immunotherapeutics (MLTX)
51.64
+1.82
(+3.65%)
USD |
NASDAQ |
Nov 21, 15:12
MoonLake Immunotherapeutics Price to Book Value: 6.671 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 6.436 |
| November 19, 2024 | 6.372 |
| November 18, 2024 | 6.270 |
| November 15, 2024 | 6.308 |
| November 14, 2024 | 6.782 |
| November 13, 2024 | 6.596 |
| November 12, 2024 | 6.703 |
| November 11, 2024 | 6.961 |
| November 08, 2024 | 6.689 |
| November 07, 2024 | 6.545 |
| November 06, 2024 | 6.650 |
| November 05, 2024 | 6.153 |
| November 04, 2024 | 5.994 |
| November 01, 2024 | 6.040 |
| October 31, 2024 | 5.995 |
| October 30, 2024 | 6.070 |
| October 29, 2024 | 6.223 |
| October 28, 2024 | 6.205 |
| October 25, 2024 | 6.031 |
| October 24, 2024 | 5.966 |
| October 23, 2024 | 6.017 |
| October 22, 2024 | 6.199 |
| October 21, 2024 | 6.330 |
| October 18, 2024 | 6.320 |
| October 17, 2024 | 6.209 |
| Date | Value |
|---|---|
| October 16, 2024 | 6.343 |
| October 15, 2024 | 6.199 |
| October 14, 2024 | 6.315 |
| October 11, 2024 | 6.320 |
| October 10, 2024 | 6.070 |
| October 09, 2024 | 6.159 |
| October 08, 2024 | 6.438 |
| October 07, 2024 | 6.682 |
| October 04, 2024 | 7.139 |
| October 03, 2024 | 6.715 |
| October 02, 2024 | 6.692 |
| October 01, 2024 | 6.679 |
| September 30, 2024 | 6.511 |
| September 27, 2024 | 5.967 |
| September 26, 2024 | 6.205 |
| September 25, 2024 | 6.137 |
| September 24, 2024 | 6.554 |
| September 23, 2024 | 6.692 |
| September 20, 2024 | 6.527 |
| September 19, 2024 | 6.487 |
| September 18, 2024 | 6.415 |
| September 17, 2024 | 6.159 |
| September 16, 2024 | 6.037 |
| September 13, 2024 | 6.177 |
| September 12, 2024 | 6.165 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.052
Minimum
Jun 30 2022
53.83
Maximum
Jun 27 2023
8.776
Average
6.205
Median
Price to Book Value Benchmarks
| Novartis AG | 4.782 |
| AC Immune SA | 2.091 |
| CRISPR Therapeutics AG | 2.024 |
| Addex Therapeutics Ltd | 0.5900 |
| NLS Pharmaceutics Ltd | -- |
Price to Book Value Related Metrics
| Price | 51.64 |
| Earnings Yield | -2.46% |
| Market Cap | 3.257B |